Atromid-S

Active Ingredient(s): Clofibrate
FDA Approved: * February 8, 1967
Pharm Company: * WYETH AYERST
Category: Cholesterol

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Atromid-S Overview

Clofibrate (trade name Atromid-S) is a lipid-lowering agent used for controlling the high cholesterol and triacylglyceride level in the blood. It belongs to the class of fibrates. It increases lipoprotein lipase activity to promote the conversion of VLDL to LDL, and hence reduce the level of VLDL. It can increase the level of HDL as well. It was patented in 1958 by Imperial Chemical Industries and approved for medical use in 1963.[1] Clofibrate was discontinued in 2002 due to ...

Read more Atromid-S Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Clofibrate

Recent Atromid-S Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Clofibrate
  • Capsule: 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Clofibrate or a similar ingredient: (1 result)